SUMMARY a 
The low radiation dose of l9"mAu means that several studies may be performed in the same patient. We have determined the feasibility of using 95mAu with a standard single crystal gamma camera and have assessed the effects of interventions on the results obtained.
Patients and methods

PATIENTS
We studied 22 patients aged 6-63 years (mean 22 5) ( Table 1) . In all left to right intracardiac shunts were suspected. Informed consent was obtained from every patient or their parents.
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METHODS
The patients were studied by means of a Technicare ON100 gamma camera. An intravenous cannula was inserted into the antecubital vein, preferably of the right arm. The detector head of the-camera was positioned over the lung field. A bolus of radionuclide, volume < 1 ml, was injected, followed by a 10-20 ml saline flush. Immediately after injection we started data acquisition with a Nodecrest V77 computer. Seventy frames of 0-5 s duration were collected for subsequent processing. The mercury-195m/gold195m generator was positioned in a shielded corner of the gamma camera room and injection therefore occurred almost immediately after elution of l9'mAu. Breakthrough of l9"mHg was minimised by eluting the generator several times and discarding the eluates which contained higher quantities of l9-mHg.
This manoeuvre was also carried out if there was an interval of > 2 minutes between consecutive elutions. At the time of injection the activity of l95mAu was approximately 550 MBq. 99mTc was given on the basis of 5 MBq/kg body weight activity.
The data collected were recalled from disc and played back in cine film form. The frames of the pulmonary phase were then identified as was the frame in which the superior vena cava and right ventricle were well delineated. Two regions of inter- Diagnosis   1  11  >3  >3  >3  -->3  ASD  2  20  >3  >3  >3  -->3  ASD  3 The fitted primary peak is subtracted from the total curve and the operator may also fit the systemic recirculation curve which can also be subtracted. In our studies we only applied the recirculation correction if there was a clear recirculation peak. Finally A2 is obtained by fitting a curve to the shunt peak which has now been isolated. The ratio ofpulmonary flow to systemic flow (Qp:Qs) is given by the formula:
A2 ±(A1-A2).
Statistics
All the results are expressed as mean (SD). The agreement between 99mTc values and oximetry values was excellent (Fig. 2) . In five patients the ratio of pulmonary flow to systemic flow was > 3:1 by both the 99mTc technique and oximetry. These results are not included in any of the graphical comparisons since quantification is inaccurate at this level of shunting. The mean deviation from the line of identity for the remaining 15 patients was -0-13(0 22).
In addition, 99mTc studies were performed on a further 17 patients with clinically normal hearts who were receiving 99mTc for bone scans. All ratios of pulmonary to systemic flow were in the range of 1-0-1-2:1 (mean (SD) 1-09(0 06)).
Results
In one patient a satisfactory gamma fit could not be obtained because of fragmentation of the bolus. In five of the patients the ratio of pulmonary flow to systemic flow was > 3:1 in both anterior and left anterior oblique 99mTc studies. In the 16 remaining patients the results of two successive anterior view l95mAu studies were compared (Fig. 3) . Mean (SD) deviation from the line of identity was 0-03 (0-12). This was not significantly different from the value found in the anterior projection. It was impossible to identify the site of shunting from the cine display. Twelve patients were studied after oxygen administration and ten after exercise. The mean ratio of pulmonary flow to systemic flow was 1-49 (0-62) after oxygen and 1-3 (0 3) after exercise. These were not significantly different from the resting values.
DOSIMETRY
To assess the radiation risk arising from the use of l95mAu the effective whole body dose equivalent (the dose to the uniformly irradiated whole body that carries the same risk as the observed non-uniform dose) was calculated using the weighting factors recommended by the International Commission on Radiological Protection.9 In our generator system, which resembles that described by Elliott et al,7 we measured a mean (SD) l9"mHg breakthrough of 96(24) kBq l95mHg per injection (n = 6), with a maximum of 120 kBq. Data for the dosimetry of l95mAu and l9smHg in animals have been published.1011 The data we used were taken from Ackers and de Jong.
" Table 2 compares the dose from a In this study we applied a recirculation correction if we could identify a good recirculation curve. '8 In most cases this correction was not essential, but occasionally it made fitting of the secondary curve easier. We found that use of intravenous cannula allowed excellent flushing of the bolus by saline without leakage and in only one case was it impossible to calculate the ratio of pulmonary flow to systemic flow. In this instance the bolus had become fragmented and even deconvolution of the curve would have proved fruitless. '9 In summary, quantification of intracardiac shunts by means of the radionuclide '9 
